Drugmaker Celltrion Inc

As SK Bioscience announced its plan to open a new R & PD center in Songdo, Incheon, three Korean bio companies called 'Big 3,' including Celltrion, Samsung Biologics, and SK Bioscience, are expected to gather in Songdo Bio-cluster.SK Bioscience announced on the 27th that it will build the global R & PD (Research & Process Development) center on a 34,413.8m^2 site in Incheon Technopark expansion complex in Songdo, Incheon. It signed a land purchase contract with the Incheon Free Economic Zone Authority on the same day.The Global R & PD Center, where institutes, factories, and offices will be located, is scheduled to be completed in the fourth quarter of 2024. The total project amount is about 300 billion won.This is the first time that SK Bioscience will build its facilities in Songdo. It is planning to expand its R & D and production infrastructure, which are currently focused in Pangyo and Andong, Gyeongbuk. The L House, SK Bioscience's vaccine production ...

Celltrion fell 9.9 per cent on Friday after its fourth-quarter revenue and earnings missed estimates

Celltrion's market cap added $15 billion this year as it rallied to a record high on January 15